View Cart  

China Launches Drug Blacklist Policy for Companies Violating Safety Laws

Drugmakers that are found to have violated China’s safety laws will now be blacklisted and their names published on the State Food and Drug Administration (SFDA) website.

To View This Article:


Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00